EP Patent

EP1253923A1 — Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses

Assigned to Biogen MA Inc · Expires 2002-11-06 · 24y expired

What this patent protects

Organic Anti-Beta 1 integrin compounds useful for inhibiting cell-adhesion.

USPTO Abstract

Organic Anti-Beta 1 integrin compounds useful for inhibiting cell-adhesion.

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: EP1253923A1
Jurisdiction: EP
Classification: —
Expires: 2002-11-06
Drug substance claim: No
Drug product claim: No
Assignee: Biogen MA Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.